AzTrials
AzTrials

Epidural PlacementNCT03378492

Utilizing Ultrasound for Residents as an Aid in Epidural Placement

A study testing Ultrasound Guided Epidural and Standard Epidural in people with Epidural Placement, run by Yale University.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

This randomized controlled trial will evaluate the use of ultrasound as an aid for epidural placement in residents performing all epidural techniques under direct staff anesthesiologist supervision. Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Epidural Placement
What is being tested?
Ultrasound Guided Epidural and Standard Epidural
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
No sites listed yet
Study dates
Aug 2018to Nov 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients presenting for vaginal delivery
  • ASA-1, ASA-2, and ASA-3
  • Patients with no known back deformities
  • Ability to sit upright for epidural placement
  • No prior lumbar surgery
  • No allergies to ultrasound gel
  • Pre-pregnancy BMI >= 30

Who cannot join

  • Patients < 18 years of age

About this study

This randomized controlled trial will evaluate the use of ultrasound as an aid for epidural placement in residents performing all epidural techniques under direct staff anesthesiologist supervision.

Read the detailed description

The purpose of this study is to assess the abilities of the "Accuro" to assist in lumbar epidural placement in patients. It is hypothesized that the use of the Accuro will result in an increase of first-attempt success rates, defined as successful epidural needle placement on the first needle insertion attempt.

Being tested
Ultrasound Guided Epidural, Standard Epidural

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ultrasound Guided EpiduralDevice

    Sterile ultrasound gel will be applied to the patient's back and the sterile device will be used to image the lumbar vertebrae in the area of the palpation-derived location. When the device is placed above the vertebral interspace, the 3D image mode will identify the spine midline and the depth from the skin to the epidural space. A single 3D ultrasound video loop of the vertebral interspace will be saved to confirm correct landmark identification. After identification of the vertebral interspace, the skin will be marked with a marking utensil or physical indentation at the point of needle entry indicated by the device. The epidural needle will then be placed in the same fashion as in the standard procedure group. The depth of the epidural needle placement will be measured and recorded following observation of loss of resistance.

  • Standard EpiduralProcedure or surgery

    The point of needle entry will be located using the landmarks technique. The specific level of epidural placement will be determined on a per-patient basis at the anesthesiologist's discretion. The spine midline will also be palpated to determine the approximate location of an interlaminar space. The needle will then be inserted at the appropriate location determined by the landmarks technique, and successful epidural placement will be confirmed by observation of loss of resistance and follow-up confirmation of analgesia. The depth of the epidural needle placement will be measured and recorded following observation of loss of resistance. The epidural catheter will be inserted and the procedure will continue according to the standard of care.

Study groups in NCT03378492
Study groupRoleWhat they receive
Standard EpiduralActive comparatorParticipants in this group will have epidurals placed using standard practice.
Receives: Procedure: Standard Epidural
Ultrasound Guided EpiduralExperimentalParticipants in this group will have epidurals placed using standard practice with the assistance of ultrasound.
Receives: Device: Ultrasound Guided Epidural

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Success Rate

    Success rates are defined as successful epidural administration on the first needle insertion attempt. This outcome will be a dichotomous (yes/no) outcome.

    Measured: Baseline (at time of procedure)

Secondary outcomes (13)
  1. Needle passes

    A needle pass is defined as any forward advancement or withdraw and forward redirection of the needle without withdraw from the skin. This outcome will capture the number of passes.

    Measured: Baseline (at time of procedure)

  2. Needle insertion attempts

    The number of needle insertion attempts is defined as advancement of the needle through the skin in an effort to enter the epidural space; a needle requiring withdrawal from the skin for reinsertion is to be counted as an additional insertion attempt.

    Measured: Baseline (at time of procedure)

  3. Accuracy of needle insertion

    The accuracy of needle insertion location is determined by the need to redirect (different angle) or reinsert the needle (different skin puncture site). This outcome will describe qualitatively the accuracy of the needle placement.

    Measured: Baseline (at time of procedure)

  4. Vertebral level of epidural placement

    Vertebral level of epidural placement is a record of the vertebral level where the epidural is administered. This will be confirmed via ultrasound imaging in both standard group and ultrasound group following epidural administration.

    Measured: Baseline (at time of procedure)

  5. Time to landmark identification

    Time to landmark identification is defined as the time interval between the start of needle puncture site identification and the time to first needle puncture attempt. The start time of needle puncture site identification in both the standard group and ultrasound group corresponds to when the resident physician first places his/her hand on the patient to palpate the back.

    Measured: Baseline (at time of procedure)

  6. Time to loss of resistance

    Time to loss of resistance is defined as the time interval between the first needle puncture attempt and the observation of loss of resistance.

    Measured: Baseline (at time of procedure)

  7. Time to complete epidural analgesia administration

    Time to complete epidural analgesia administration is defined as the time interval between the observation of loss of resistance and administration of analgesics through the epidural catheter.

    Measured: Baseline (at time of procedure)

  8. Total technical procedure time

    Total technical procedure time is defined as the sum of (iv) Time to landmark identification, (v) Time to loss of resistance, and (vi) Time to complete epidural analgesia administration. This technical procedure time measure the time between first placing hands on the patient to the administration of analgesia.

    Measured: Baseline (at time of procedure)

  9. Epidural space depth

    Epidural space depth is the depth from the skin to the epidural space as measured in centimeters (accurate to 0.1 cm).

    Measured: Baseline (at time of procedure)

  10. Pain

    Pain during epidural administration: to be assessed after the completion of catheter insertion (verbal rating scale [VRS], 0-10, 0 = no pain, 10 = maximum pain).

    Measured: Baseline (at time of procedure)

  11. Analgesia efficacy rate

    Analgesia efficacy rate: defined as VRS <= 1 and absence of unilateral or failed block at 20 minutes after injection of the loading dose

    Measured: Baseline (at time of procedure)

  12. Time to comfort

    Time to comfort after administration of the loading dose will be recorded in minutes.

    Measured: Baseline (at time of procedure)

  13. Patient satisfaction

    Patient satisfaction with the epidural administration, assessed after the administration of the loading dose (scale 0-10, 0 = not satisfied, 10 = completely satisfied).

    Measured: Follow Up (Up to 1 day)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Dec 2017
  2. Study startAug 2018 (estimated)
  3. Primary completionNov 2019 (estimated)
  4. Study completionNov 2020 (estimated)

Why it stopped: Study did not enroll, was closed

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03378492
Sponsor's protocol ID
2000021722
Status last verified
Jan 2019
First submitted
12 Dec 2017
Last updated
10 Jan 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Ultrasound Guided Epidural and Standard Epidural in people with Epidural Placement, run by Yale University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 10 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Success Rate (time frame: Baseline (at time of procedure)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in